Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2021		83,659,665
Beginning balance at Dec. 31, 2021	$ 807,078	$ 8	$ 740,849	$ 66,221
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		888,961
Issuance of common stock upon exercise of stock options	5,626	$ 1	5,625
Issuance of common stock upon settlement of restricted stock units (in shares)		80,226
Stock-based compensation expense	26,677		26,677
Issuance of common stock under employee stock purchase plan (in shares)		47,894
Issuance of common stock under employee stock purchase plan	4,431		4,431
Net income (loss)	32,692			32,692
Ending balance (in shares) at Mar. 31, 2022		84,676,746
Ending balance at Mar. 31, 2022	$ 876,504	$ 9	777,582	98,913
Beginning balance (in shares) at Dec. 31, 2022	81,259,676	81,259,676
Beginning balance at Dec. 31, 2022	$ 672,435	$ 8	714,871	(42,444)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	331,093	331,093
Issuance of common stock upon exercise of stock options	$ 1,537		1,537
Issuance of common stock upon settlement of restricted stock units (in shares)		698,173
Shares withheld related to net share settlement of restricted stock units (in shares)		(328)
Shares withheld related to net share settlement of restricted stock units	(5)		(5)
Stock-based compensation expense	76,767		76,767
Issuance of common stock under employee stock purchase plan (in shares)		312,134
Issuance of common stock under employee stock purchase plan	5,728		5,728
Net income (loss)	$ (129,254)			(129,254)
Ending balance (in shares) at Mar. 31, 2023	82,600,748	82,600,748
Ending balance at Mar. 31, 2023	$ 627,208	$ 8	$ 798,898	$ (171,698)